{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:21:38Z","timestamp":1791231698907,"version":"4.1.0"},"reference-count":183,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Deliv."],"abstract":"<jats:p>Neurodegenerative diseases (NDs) have become a serious global health problem as the population ages. Traditionally, treatment strategies for NDs have included oral and intravenous administration; however, the blood\u2013brain barrier (BBB) can prevent drugs from reaching the brain, rendering the treatment incomplete and the effect unsatisfactory. Additionally, the prolonged or excessive use of drugs that can cross the BBB can damage liver and kidney function. Recent studies have shown that nose-to-brain drug delivery can noninvasively bypass the BBB, allowing drugs to enter the brain through the olfactory or trigeminal nerve pathways; additionally, nanoparticle carriers can enhance drug delivery. This review introduces drug carrier nanoparticles for nose-to-brain delivery systems, compares the advantages and disadvantages of different nanoparticles, and discusses the factors influencing nose-to-brain nanomedicine delivery and enhancement strategies. We also summarize nose-to-brain delivery and nanomedicines for treating NDs, the current challenges of this approach, and the future promise of nanomedicine-based ND treatment.<\/jats:p>","DOI":"10.3389\/fddev.2023.1247162","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:10:28Z","timestamp":1691766628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Transnasal-brain delivery of nanomedicines for neurodegenerative diseases"],"prefix":"10.3389","volume":"3","author":[{"given":"Xu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwu","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/pharmaceutics10020040","article-title":"In situ-based gels for nose to brain delivery for the treatment of neurological diseases","volume":"10","author":"Aderibigbe","year":"2018","journal-title":"Pharmaceutics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1164\/arrd.1972.106.1.86","article-title":"Physical properties of sputum. 3. Rheologic variability and intrinsic relationships","volume":"106","author":"Adler","year":"1972","journal-title":"Am. Rev. Respir. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"Stimuli-responsive in situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.3390\/biomedicines10092182","article-title":"Brain gene silencing with cationic amino-capped poly(ethylene glycol) polyplexes","volume":"10","author":"Alamoudi","year":"2022","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.2147\/IJN.S210876","article-title":"Recent expansions of novel strategies towards the drug targeting into the brain","volume":"14","author":"Alexander","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nano.2018.11.006","article-title":"Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brain","volume":"16","author":"Aly","year":"2019","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1756-6606-6-47","article-title":"Exosomes neutralize synaptic-plasticity-disrupting activity of A\u03b2 assemblies in vivo","volume":"6","author":"An","year":"2013","journal-title":"Mol. Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/s1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/pharmaceutics12121230","article-title":"Intranasal nanoemulsions for direct nose-to-brain delivery of actives for CNS disorders","volume":"12","author":"Bahadur","year":"2020","journal-title":"Pharmaceutics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/s415","article-title":"Parkinson's disease: a review","volume":"6","author":"Beitz","year":"2014","journal-title":"Front. Biosci. (Scholar Ed."},{"key":"B13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/nan.12520","article-title":"Invited Review: from nose to gut - the role of the microbiome in neurological disease","volume":"45","author":"Bell","year":"2019","journal-title":"Neuropathology Appl. Neurobiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2174\/1381612826666200115101544","article-title":"Nose-to-brain delivery of natural compounds for the treatment of central nervous system disorders","volume":"26","author":"Bicker","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"B15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/ijnp\/pyx012","article-title":"Discontinuation, efficacy, and safety of cholinesterase inhibitors for alzheimer's disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16 106 patients","volume":"20","author":"Blanco-Silvente","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/pharmaceutics11020084","article-title":"Nanoemulsions for \"Nose-to-Brain\" drug delivery","volume":"11","author":"Bonferoni","year":"2019","journal-title":"Pharmaceutics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on alzheimer's disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Mol. (Basel, Switz."},{"key":"B18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/10611860108997935","article-title":"Transport of nanoparticles across the rat nasal mucosa","volume":"9","author":"Brooking","year":"2001","journal-title":"J. Drug Target."},{"key":"B20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.supflu.2015.09.007","article-title":"Efficient encapsulation of proteins in submicro liposomes using a supercritical fluid assisted continuous process","volume":"107","author":"Campardelli","year":"2016","journal-title":"J. Supercrit. Fluids"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejps.2006.11.018","article-title":"Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device","volume":"30","author":"Charlton","year":"2007","journal-title":"Eur. J. Pharm. Sci. Official J. Eur. Fed. For Pharm. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s11095-008-9550-2","article-title":"Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model","volume":"25","author":"Charlton","year":"2008","journal-title":"Pharm. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/1061186X.2011.622396","article-title":"Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations","volume":"20","author":"Chen","year":"2012","journal-title":"J. Drug Target."},{"key":"B25","doi-asserted-by":"publisher","first-page":"119115","DOI":"10.1016\/j.ijpharm.2020.119115","article-title":"Nasal timosaponin BII dually sensitive in situ hydrogels for the prevention of Alzheimer's disease induced by lipopolysaccharides","volume":"578","author":"Chen","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.exger.2005.09.004","article-title":"Proteasome dysfunction in mammalian aging: steps and factors involved","volume":"40","author":"Chondrogianni","year":"2005","journal-title":"Exp. Gerontol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","article-title":"Structure and fate of nanoparticles designed for the nasal delivery of poorly soluble drugs","volume":"18","author":"Clementino","year":"2021","journal-title":"Mol. Pharm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jps.2600790304","article-title":"Characterization of the barrier properties of mucosal membranes","volume":"79","author":"Corbo","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"114485","DOI":"10.1016\/j.addr.2022.114485","article-title":"Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders","volume":"189","author":"Correia","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Archives Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","article-title":"Lipid nanoparticles for nasal\/intranasal drug delivery","volume":"34","author":"Cunha","year":"2017","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s11011-021-00765-w","article-title":"Role of metals in Alzheimer's disease","volume":"36","author":"Das","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jconrel.2020.02.033","article-title":"Nasal administration of nanoencapsulated geraniol\/ursodeoxycholic acid conjugate: towards a new approach for the management of Parkinson's disease","volume":"321","author":"De Oliveira Junior","year":"2020","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1021\/cr040002s","article-title":"Controlled ring-opening polymerization of lactide and glycolide","volume":"104","author":"Dechy-Cabaret","year":"2004","journal-title":"Chem. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1016\/j.vaccine.2009.03.034","article-title":"Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy","volume":"27","author":"Demento","year":"2009","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/jamp.2011.0924","article-title":"Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump","volume":"25","author":"Djupesland","year":"2012","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1136\/gutjnl-2018-317503","article-title":"Role of the microbiome in human development","volume":"68","author":"Dominguez-Bello","year":"2019","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"11133","DOI":"10.1002\/anie.201504884","article-title":"A cell-penetrating foldamer with a bioreducible linkage for intracellular delivery of DNA","volume":"54","author":"Douat","year":"2015","journal-title":"Angewandte Chemie Int. Ed. Engl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12033-010-9334-x","article-title":"Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions","volume":"47","author":"Dreyer","year":"2011","journal-title":"Mol. Biotechnol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.lfs.2019.02.058","article-title":"Targeting of thymoquinone-loaded mesoporous silica nanoparticles to different brain areas: in vivo study","volume":"222","author":"Fahmy","year":"2019","journal-title":"Life Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"E171","DOI":"10.1208\/aapsj0902019","article-title":"Nanosystems for simultaneous imaging and drug delivery to T cells","volume":"9","author":"Fahmy","year":"2007","journal-title":"AAPS J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018024697","article-title":"Updated progress of nanocarrier-based intranasal drug delivery systems for treatment of brain diseases","volume":"35","author":"Fan","year":"2018","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1038\/s41598-021-84605-y","article-title":"Differential effect of anesthetics on mucociliary clearance in vivo in mice","volume":"11","author":"Feldman","year":"2021","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/nano11030563","article-title":"Critical review of lipid-based nanoparticles as carriers of neuroprotective drugs and extracts","volume":"11","author":"Fernandes","year":"2021","journal-title":"Nanomater. (Basel)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/jam.2007.0638","article-title":"The influence of spray properties on intranasal deposition","volume":"20","author":"Foo","year":"2007","journal-title":"J. Aerosol Med. Official J. Int. Soc. For Aerosols Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"119957","DOI":"10.1016\/j.ijpharm.2020.119957","article-title":"Intranasal administration of gold nanoparticles designed to target the central nervous system: fabrication and comparison between nanospheres and nanoprisms","volume":"590","author":"Gallardo-Toledo","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.31782\/IJCRR.2020.121929","article-title":"Gellan gum assisted fabrication and characterization of donepezil hydrochloride mucoadhesive intranasal microspheres","volume":"12","author":"Gangane","year":"2020","journal-title":"Int. J. Curr. Res. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2007.05.026","article-title":"Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration","volume":"121","author":"Gao","year":"2007","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B51","doi-asserted-by":"publisher","first-page":"111829","DOI":"10.1016\/j.biopha.2021.111829","article-title":"Systematic development of lectin conjugated microspheres for nose-to-brain delivery of rivastigmine for the treatment of Alzheimer's disease","volume":"141","author":"Gao","year":"2021","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0169-409x(93)90015-v","article-title":"The relevance of nasal physiology to the design of drug absorption studies","volume":"11","author":"Gizurarson","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"949724","DOI":"10.3389\/fbioe.2022.949724","article-title":"Safety and biodistribution of exosomes derived from human induced pluripotent stem cells","volume":"10","author":"Gu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/10717544.2020.1760960","article-title":"RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery","volume":"27","author":"Hao","year":"2020","journal-title":"Drug Deliv."},{"key":"B57","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.2042-7158.1985.tb05069.x","article-title":"Intranasal drug delivery by spray and drops","volume":"37","author":"Hardy","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.nut.2009.08.003","article-title":"Intranasal insulin: from nose to brain","volume":"26","author":"Henkin","year":"2010","journal-title":"Nutr. (Burbank, Los Angel. Cty. Calif.)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.17925\/USN.2020.16.1.25","article-title":"The upper nasal space\u2014a novel delivery route ideal for central nervous system drugs","volume":"16","author":"Hoekman","year":"2020","journal-title":"Drug Deliv."},{"key":"B60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and recent progress in oral drug delivery systems for biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/jps.2600740605","article-title":"Mechanism of nasal absorption of drugs I: physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats","volume":"74","author":"Huang","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain Abeta by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Sci. (New York, N.Y.)."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.12659\/MSM.914027","article-title":"Exosomes in pathogenesis, diagnosis, and treatment of alzheimer's disease","volume":"25","author":"Jiang","year":"","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.2147\/IJN.S214657","article-title":"The optimization design of lactoferrin loaded HupA nanoemulsion for targeted drug transport via intranasal route","volume":"14","author":"Jiang","year":"","journal-title":"Int. J. Nanomedicine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0169-409x(01)00172-7","article-title":"The nose and paranasal sinuses physiology and anatomy","volume":"51","author":"Jones","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B67","first-page":"269","article-title":"A recent review on nasal drug delivery system","volume":"4","author":"Kakad","year":"2015","journal-title":"World J. Pharm. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"key":"B69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijpharm.2017.07.077","article-title":"Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide","volume":"530","author":"Kanazawa","year":"2017","journal-title":"Int. J. Pharm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1023\/a:1007583422634","article-title":"Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs","volume":"17","author":"Kao","year":"2000","journal-title":"Pharm. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1567201816666191029122740","article-title":"Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges","volume":"16","author":"Kashyap","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/srep01197","article-title":"Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes","volume":"3","author":"Katsuda","year":"2013","journal-title":"Sci. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3109\/21691401.2015.1012260","article-title":"In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane","volume":"44","author":"Kaur","year":"2016","journal-title":"Artif. Cells, Nanomedicine, Biotechnol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40005-019-00434-2","article-title":"Solubility enhancement and application of cyclodextrins in local drug delivery","volume":"50","author":"Kim","year":"2020","journal-title":"J. Pharm. investigation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.nano.2016.01.002","article-title":"Robust neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the postischemic brain","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.3390\/nu11102549","article-title":"Characteristics and glucose uptake promoting effect of chrysin-loaded phytosomes prepared with different phospholipid matrices","volume":"11","author":"Kim","year":"2019","journal-title":"Nutrients"},{"key":"B77","doi-asserted-by":"publisher","first-page":"122188","DOI":"10.1016\/j.ijpharm.2022.122188","article-title":"Preparation and detailed characterization of the thiomer chitosan-cysteine as a suitable mucoadhesive excipient for nasal powders","volume":"626","author":"Kiss","year":"2022","journal-title":"Int. J. Pharm."},{"key":"B78","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/ijms17020185","article-title":"Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos","volume":"17","author":"Kristensen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"435101","DOI":"10.1088\/0957-4484\/27\/43\/435101","article-title":"Design Expert(\u00ae) supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson's disease","volume":"27","author":"Kumar","year":"2016","journal-title":"Nanotechnology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"120994","DOI":"10.1016\/j.ijpharm.2021.120994","article-title":"Progress in nasal drug delivery systems","volume":"607","author":"Laffleur","year":"2021","journal-title":"Int. J. Pharm."},{"key":"B81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1479-5876-9-9","article-title":"Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages","volume":"9","author":"L\u00e4sser","year":"2011","journal-title":"J. Transl. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2016.01.004","article-title":"Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss","volume":"108","author":"Li","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/03639045.2013.858734","article-title":"Pharmacokinetics and efficiency of brain targeting of ginsenosides Rg1 and Rb1 given as Nao-Qing microemulsion","volume":"41","author":"Li","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/s0531-5565(01)00140-1","article-title":"Age-dependent deamidation of asparagine residues in proteins","volume":"36","author":"Lindner","year":"2001","journal-title":"Exp. Gerontol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s11095-011-0641-0","article-title":"Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles","volume":"29","author":"Liu","year":"2012","journal-title":"Pharm. Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.foodchem.2014.11.108","article-title":"Behaviour of liposomes loaded with bovine serum albumin during in vitro digestion","volume":"175","author":"Liu","year":"2015","journal-title":"Food Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","article-title":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"B88","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","article-title":"Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration","volume":"35","author":"Lochhead","year":"2015","journal-title":"J. Cereb. Blood Flow Metabolism Official J. Int. Soc. Cereb. Blood Flow Metabolism"},{"key":"B89","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs","volume":"36","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"key":"B90","doi-asserted-by":"publisher","first-page":"CD001747","DOI":"10.1002\/14651858.CD001747","article-title":"Galantamine for Alzheimer's disease and mild cognitive impairment","volume":"2006","author":"Loy","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF01002469","article-title":"Lectin-binding pattern of neuroepithelial and respiratory epithelial cells in the mouse nasal cavity","volume":"21","author":"Lundh","year":"1989","journal-title":"Histochem. J."},{"key":"B92","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/jamp.2009.0766","article-title":"Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines","volume":"23","author":"Makidon","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.3390\/molecules25204866","article-title":"Use of biodegradable, chitosan-based nanoparticles in the treatment of alzheimer's disease","volume":"25","author":"Manek","year":"2020","journal-title":"Molecules"},{"key":"B94","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jps.2600760709","article-title":"Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity","volume":"76","author":"Mcmartin","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/alzrt225","article-title":"Nanoparticulate flurbiprofen reduces amyloid-\u03b242 generation in an in vitro blood-brain barrier model","volume":"5","author":"Meister","year":"2013","journal-title":"Alzheimer's Res. Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0169-409x(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B97","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.biopha.2018.05.067","article-title":"Nano strategies for berberine delivery, a natural alkaloid of Berberis","volume":"104","author":"Mirhadi","year":"2018","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.2174\/138920112803341752","article-title":"Drug delivery systems from nose to brain","volume":"13","author":"Misra","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.addr.2003.10.020","article-title":"High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids","volume":"56","author":"Morissette","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/pharmaceutics14081542","article-title":"Mesoporous materials as elements of modern drug delivery systems for anti-inflammatory agents: a review of recent achievements","volume":"14","author":"Moritz","year":"2022","journal-title":"Pharmaceutics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.2042-7158.1994.tb03746.x","article-title":"Factors influencing gel-strengthening at the mucoadhesive-mucus interface","volume":"46","author":"Mortazavi","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejps.2016.05.012","article-title":"Intranasal delivery of nanoparticle encapsulated tarenflurbil: a potential brain targeting strategy for alzheimer's disease","volume":"92","author":"Muntimadugu","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/antiox10060887","article-title":"Micellar nanocarriers of hydroxytyrosol are protective against Parkinson's related oxidative stress in an in vitro hCMEC\/D3-SH-SY5Y Co-culture system","volume":"10","author":"Mursaleen","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/pharmaceutics11030118","article-title":"Epilepsy disease and nose-to-brain delivery of polymeric nanoparticles: an overview","volume":"11","author":"Musumeci","year":"2019","journal-title":"Pharmaceutics"},{"key":"B105","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"B106","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/10717544.2016.1276232","article-title":"Basic concepts and recent advances in nanogels as carriers for medical applications","volume":"24","author":"Neamtu","year":"2017","journal-title":"Drug Deliv."},{"key":"B107","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fpsyt.2010.00007","article-title":"Challenges in neurodegeneration research","volume":"1","author":"Noble","year":"2010","journal-title":"Front. Psychiatry"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal delivery of high molecular weight drugs","volume":"14","author":"Ozsoy","year":"2009","journal-title":"Mol. (Basel)"},{"key":"B109","doi-asserted-by":"publisher","first-page":"485102","DOI":"10.1088\/0957-4484\/25\/48\/485102","article-title":"Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress","volume":"25","author":"Pangeni","year":"2014","journal-title":"Nanotechnology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbr.2018.01.003","article-title":"Cognitive decline and increased hippocampal p-tau expression in mice with hearing loss","volume":"342","author":"Park","year":"2018","journal-title":"Behav. Brain Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","article-title":"Microenvironmental pH is a key factor for exosome traffic in tumor cells","volume":"284","author":"Parolini","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1021\/acschemneuro.9b00581","article-title":"Efficacy of cholesterol nose-to-brain delivery for brain targeting in huntington's disease","volume":"11","author":"Passoni","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0036-1597950","article-title":"Nasal anatomy and function","volume":"33","author":"Patel","year":"2017","journal-title":"Facial Plast. Surg. FPS"},{"key":"B114","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","article-title":"Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route","volume":"4","author":"Pathak","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"B116","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08982104.2018.1552703","article-title":"Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain","volume":"29","author":"Patil","year":"2019","journal-title":"J. Liposome Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/pharmaceutics13050680","article-title":"Crocetin as new cross-linker for bioactive sericin nanoparticles","volume":"13","author":"Perteghella","year":"2021","journal-title":"Pharmaceutics"},{"key":"B118","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1532-5415.1988.tb04363.x","article-title":"Hearing impairment as a predictor of cognitive decline in dementia","volume":"36","author":"Peters","year":"1988","journal-title":"J. Am. Geriatrics Soc."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/pharmaceutics14061136","article-title":"Gene targeting to the cerebral cortex following intranasal administration of polyplexes","volume":"14","author":"Petkova","year":"2022","journal-title":"Pharmaceutics"},{"key":"B120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biomaterials.2015.11.057","article-title":"Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease","volume":"80","author":"Picone","year":"2016","journal-title":"Biomaterials"},{"key":"B121","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2017.11.040","article-title":"Nose-to-brain delivery of insulin enhanced by a nanogel carrier","volume":"270","author":"Picone","year":"2018","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B122","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/17425247.2022.2029845","article-title":"Nose-to-brain drug delivery for the treatment of alzheimer's disease: current advancements and challenges","volume":"19","author":"Prabakaran","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e20190062","DOI":"10.1084\/jem.20190062","article-title":"The blood-brain barrier in health and disease: important unanswered questions","volume":"217","author":"Profaci","year":"2020","journal-title":"J. Exp. Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e0255778","DOI":"10.1371\/journal.pone.0255778","article-title":"IFN\u03b3-stimulated dendritic cell extracellular vesicles can be nasally administered to the brain and enter oligodendrocytes","volume":"16","author":"Pusic","year":"2021","journal-title":"PloS One"},{"key":"B125","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijpharm.2014.04.015","article-title":"Development, characterization and application of in situ gel systems for intranasal delivery of tacrine","volume":"468","author":"Qian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"B126","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/mp.2015.166","article-title":"The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders","volume":"21","author":"Quintana","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B127","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/03639045.2016.1225754","article-title":"Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson's disease","volume":"43","author":"Rao","year":"2017","journal-title":"Drug Dev. Industrial Pharm."},{"key":"B128","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1111\/j.1526-4610.2006.00603.x","article-title":"Nasal delivery of antimigraine drugs: clinical rationale and evidence base","volume":"4","author":"Rapoport","year":"2006","journal-title":"Headache J. Head Face Pain"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/pharmaceutics13111897","article-title":"Nanoparticle-guided brain drug delivery: expanding the therapeutic approach to neurodegenerative diseases","volume":"13","author":"Riccardi","year":"2021","journal-title":"Pharmaceutics"},{"key":"B130","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1208\/s12248-015-9724-x","article-title":"Emerging insights for translational pharmacokinetic and pharmacokinetic-pharmacodynamic studies: towards prediction of nose-to-brain transport in humans","volume":"17","author":"Ruigrok","year":"2015","journal-title":"AAPS J."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.lfs.2006.06.011","article-title":"Therapeutic potential of RNA interference for neurological disorders","volume":"79","author":"Sah","year":"2006","journal-title":"Life Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00018-009-0186-0","article-title":"Cell penetrating peptides: overview and applications to the delivery of oligonucleotides","volume":"67","author":"Said Hassane","year":"2010","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"B133","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.colsurfb.2017.08.031","article-title":"Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: development, characterization, ex vivo permeation and cellular studies","volume":"159","author":"Salatin","year":"2017","journal-title":"Colloids Surfaces. B, Biointerfaces."},{"key":"B134","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jddst.2017.11.013","article-title":"Chitosan-Mangafodipir nanoparticles designed for intranasal delivery of siRNA and DNA to brain","volume":"43","author":"Sanchez-Ramos","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"102119","DOI":"10.1016\/j.nano.2019.102119","article-title":"Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration","volume":"24","author":"Sava","year":"2020","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"102517","DOI":"10.1016\/j.jddst.2021.102517","article-title":"Kinetics of HTT lowering in brain of YAC 128 mice following single and repetitive intranasal dosing of siRNA packaged in chitosan-based nanoparticle","volume":"63","author":"Sava","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e1004972","DOI":"10.1371\/journal.pgen.1004972","article-title":"Mitochondrial and cytoplasmic ROS have opposing effects on lifespan","volume":"11","author":"Schaar","year":"2015","journal-title":"PLoS Genet."},{"key":"B138","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0006-8993(78)90140-3","article-title":"Labeled wheat germ agglutinin (WGA) as a new, highly sensitive retrograde tracer in the rat brain hippocampal system","volume":"152","author":"Schwab","year":"1978","journal-title":"Brain Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0975-7406.76478","article-title":"Mucoadhesive drug delivery systems","volume":"1","author":"Shaikh","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/ijms17060806","article-title":"The role of cell-penetrating peptide and transferrin on enhanced delivery of drug to brain","volume":"17","author":"Sharma","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3109\/03639045.2013.789051","article-title":"Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery","volume":"40","author":"Sharma","year":"2014","journal-title":"Drug Dev. Industrial Pharm."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2174\/0929867324666170830102409","article-title":"Stimuli-responsive carriers for controlled intracellular drug release","volume":"26","author":"Sheng","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"B143","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1007\/s12035-019-1588-0","article-title":"A new neural pathway from the ventral striatum to the nucleus basalis of meynert with functional implication to learning and memory","volume":"56","author":"Shu","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","article-title":"The basics and underlying mechanisms of mucoadhesion","volume":"57","author":"Smart","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B146","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1166\/jbn.2015.1962","article-title":"Nanocomposite hydrogels and their applications in drug delivery and tissue engineering","volume":"11","author":"Song","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","article-title":"Huntington's disease: diagnosis and management","volume":"22","author":"Stoker","year":"2022","journal-title":"Pract. Neurol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","article-title":"Gene therapy for neurodegenerative diseases","volume":"16","author":"Sudhakar","year":"2019","journal-title":"Neurother. J. Am. Soc. For Exp. Neurother."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"B151","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1567201815666181004094707","article-title":"Nose to brain delivery of galantamine loaded nanoparticles: in-vivo pharmacodynamic and biochemical study in mice","volume":"16","author":"Sunena","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"B152","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2015.10.004","article-title":"Current advances in self-assembled nanogel delivery systems for immunotherapy","volume":"95","author":"Tahara","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B153","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/17425247.2020.1762563","article-title":"Nose-to-brain delivery of antipsychotics using nanotechnology: a review","volume":"17","author":"Tan","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"B154","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s0896-6273(00)00119-7","article-title":"FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine\/paracrine cofactor","volume":"28","author":"Taupin","year":"2000","journal-title":"Neuron"},{"key":"B155","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"B157","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1517\/14712598.1.1.49","article-title":"Prodrugs in nasal drug delivery","volume":"1","author":"Tirucherai","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"B158","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1517\/17425247.5.2.155","article-title":"Polymeric nanoparticles for the drug delivery to the central nervous system","volume":"5","author":"Tosi","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"B159","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00453544","article-title":"Interaction between mucociliary transport and the ciliary beat of chicken nasal mucosa","volume":"242","author":"Ukai","year":"1985","journal-title":"Archives Oto-rhino-laryngology."},{"key":"B160","doi-asserted-by":"publisher","first-page":"108832","DOI":"10.1016\/j.neuropharm.2021.108832","article-title":"Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability","volume":"201","author":"Uppuluri","year":"2021","journal-title":"Neuropharmacology"},{"key":"B161","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/10611860701603372","article-title":"Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery","volume":"15","author":"Vauthier","year":"2007","journal-title":"J. Drug Target."},{"key":"B162","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0169-409x(97)00067-7","article-title":"Nasal delivery systems and their effect on deposition and absorption","volume":"29","author":"Vidgren","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B163","volume-title":"First insights into non-invasive administration routes for non-viral gene therapy. Gene therapy: principles and challenges","author":"Villatebeitia","year":"2015"},{"key":"B164","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1523\/JNEUROSCI.6476-10.2011","article-title":"Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes","volume":"31","author":"Wang","year":"2011","journal-title":"J. Neurosci. Official J. Soc. For Neurosci."},{"key":"B165","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4103\/1673-5374.346484","article-title":"The lymphatic drainage systems in the brain: a novel target for ischemic stroke?","volume":"18","author":"Wang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"B166","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jddst.2016.05.003","article-title":"Formulation and device design to increase nose to brain drug delivery","volume":"35","author":"Warnken","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"eabd6889","DOI":"10.1126\/sciadv.abd6889","article-title":"BBB pathophysiology-independent delivery of siRNA in traumatic brain injury","volume":"7","author":"Wen","year":"2021","journal-title":"Sci. Adv."},{"key":"B168","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12938-015-0034-4","article-title":"Model demonstrates functional purpose of the nasal cycle","volume":"14","author":"White","year":"2015","journal-title":"Biomed. Eng. Online"},{"key":"B169","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nmat2444","article-title":"Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA","volume":"8","author":"Woodrow","year":"2009","journal-title":"Nat. Mater."},{"key":"B170","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"106189","DOI":"10.1016\/j.phrs.2022.106189","article-title":"Dual role of the nasal microbiota in neurological diseases-An unignorable risk factor or a potential therapy carrier","volume":"179","author":"Xie","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B172","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.xphs.2016.05.017","article-title":"Neuroprotective effects of engineered polymeric nasal microspheres containing hydroxypropyl-\u03b2-cyclodextrin on \u03b2-amyloid (1-42)-induced toxicity","volume":"105","author":"Yalcin","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"B173","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.nano.2009.11.007","article-title":"Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease","volume":"6","author":"Yang","year":"2010","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3389\/fphar.2020.01165","article-title":"Intranasal delivery of targeted nanoparticles loaded with miR-132 to brain for the treatment of neurodegenerative diseases","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2019.02.012","article-title":"Chitosan and chitosan coating nanoparticles for the treatment of brain disease","volume":"560","author":"Yu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"B176","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","article-title":"Sphingolipid-modulated exosome secretion promotes clearance of amyloid-\u03b2 by microglia","volume":"287","author":"Yuyama","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B177","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijpharm.2013.11.049","article-title":"Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease","volume":"461","author":"Zhang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"B178","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2016.03.020","article-title":"Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems","volume":"229","author":"Zhang","year":"2016","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B179","doi-asserted-by":"publisher","first-page":"119981","DOI":"10.1016\/j.ijpharm.2020.119981","article-title":"Poly (ethylene glycol)-block-poly (D, L-lactide) (PEG-PLA) micelles for brain delivery of baicalein through nasal route for potential treatment of neurodegenerative diseases due to oxidative stress and inflammation: an in vitro and in vivo study","volume":"591","author":"Zhang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","article-title":"The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson's disease","volume":"28","author":"Zhao","year":"2021","journal-title":"Cell. Death Differ."},{"key":"B181","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuint.2017.03.017","article-title":"DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice","volume":"111","author":"Zhao","year":"2017","journal-title":"Neurochem. Int."},{"key":"B182","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."}],"container-title":["Frontiers in Drug Delivery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddev.2023.1247162\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:10:36Z","timestamp":1691766636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddev.2023.1247162\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":183,"alternative-id":["10.3389\/fddev.2023.1247162"],"URL":"https:\/\/doi.org\/10.3389\/fddev.2023.1247162","relation":{},"ISSN":["2674-0850"],"issn-type":[{"value":"2674-0850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"article-number":"1247162"}}